(in millions $) | 30 Sep 2023 | 31 Mar 2023 | 30 Sep 2022 | 31 Mar 2022 |
---|---|---|---|---|
Current assets | ||||
Cash | $456026.3 | $291403.3 | $313864.8 | $68409.4 |
Short term investments | $51696.7 | $51689 | $51545.9 | $106365.7 |
Net receivables | $207294.8 | $193432 | $174737.4 | $198011.3 |
Inventory | $543012.1 | $442380.7 | $493928.2 | $541631 |
Total current assets | $1452854.4 | $1141505.3 | $1349363.6 | $1060592.9 |
Long term investments | $763006.2 | $737037.1 | $658891.2 | $692711.6 |
Property, plant & equipment | $3315420.4 | $3117797.2 | $3202856.1 | $3136457.7 |
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $6690819.9 | $6145287.3 | $6285571.5 | $5854493.2 |
Current liabilities | ||||
Accounts payable | $367891.2 | $336426 | $326651.9 | $401710.7 |
Deferred revenue | ||||
Short long term debt | $362565.5 | $354917.4 | $470338.6 | $247264.6 |
Total current liabilities | $1454158.3 | $1322701.7 | $1414201.7 | $1274242.8 |
Long term debt | $1072396.9 | $1071948.4 | $1096172.8 | $972594 |
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $3326809.4 | $3132736.9 | $3313430.2 | $3259464.1 |
Shareholders' equity | ||||
Retained earnings | $2747444.1 | $2532127.7 | ||
Other shareholder equity | $3301109.1 | $2949649 | $2909239.9 | $202308.69 |
Total shareholder equity | $3364010.5 | $3012550.4 | $2972141.3 | $2595029.1 |
(in millions $) | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 | 31 Mar 2020 |
---|---|---|---|---|
Current assets | ||||
Cash | $291403.3 | $68409.4 | $40193.69 | $47805.62 |
Short term investments | $51689 | $106365.7 | $84323.74 | $101188.35 |
Net receivables | $193432 | $198011.3 | $333114.83 | $299422.49 |
Inventory | $442380.7 | $541631 | $445733.26 | $330512.03 |
Total current assets | $1141505.3 | $1060592.9 | $931841.64 | $807094.51 |
Long term investments | $737037.1 | $692711.6 | $546124.56 | $514181.86 |
Property, plant & equipment | $3117797.2 | $3136457.7 | $2922344.38 | $2747189.24 |
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $6145287.3 | $5854493.2 | $5432646.13 | $5100176.14 |
Current liabilities | ||||
Accounts payable | $336426 | $401710.7 | $274491.45 | $229611.26 |
Deferred revenue | ||||
Short long term debt | $354917.4 | $247264.6 | $443786.56 | $485260.74 |
Total current liabilities | $1322701.7 | $1274242.8 | $1232647.45 | $1250725.76 |
Long term debt | $1071948.4 | $972594 | $888082.65 | $809464.42 |
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $3132736.9 | $3259464.1 | $3222836.24 | $3049130.11 |
Shareholders' equity | ||||
Retained earnings | $2747444.1 | $2532127.7 | $1901747.54 | $1761854.97 |
Other shareholder equity | $2949649 | $202308.69 | $245160.96 | $226289.52 |
Total shareholder equity | $3012550.4 | $2595029.1 | $2209809.89 | $2051046.03 |
(in millions $) | 30 Jun 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $1665767.5 | $1655690.6 | $1468737.3 | $1638235.9 |
Cost of revenue | $1092559.4 | $1096677.8 | $826829.5 | $1004620.3 |
Gross Profit | $573208.1 | $559012.8 | $641907.8 | $633615.6 |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $25341.4 | $26306.5 | $21041.4 | $30303.8 |
Total operating expenses | $1528579.5 | $1526389.5 | $1253164.8 | $1407891.2 |
Operating income | $137188 | $129301.1 | $215572.5 | $230344.7 |
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $37453.7 | $37679.2 | $56335.8 | $63568.4 |
Interest expense | -$29383.6 | -$25441.2 | -$26033.4 | -$23639.4 |
Net income | ||||
Net income | $99364.5 | $103564.4 | $137341.1 | $141339.1 |
Income (for common shares) | $99364.5 | $103564.4 | $137341.1 | $141339.1 |
(in millions $) | 31 Dec 2022 | 31 Mar 2022 | 31 Mar 2021 | 31 Mar 2020 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $5261745 | $5317618.3 | $3605723.1 | $4249610.75 |
Cost of revenue | $3536569.3 | $3318612 | $2571698.88 | $3072517.35 |
Gross Profit | $1725175.7 | $1999006.3 | $1034024.22 | $1177093.4 |
Operating activities | ||||
Research & development | $5133.08 | $58931.4 | $76896.71 | $95791.84 |
Selling, general & administrative | $105066.8 | $782446.7 | $423260.69 | $509244.18 |
Total operating expenses | $4840701.2 | $4808762.4 | $3355225.83 | $4083148.93 |
Operating income | $421043.8 | $508855.9 | $250497.27 | $166461.82 |
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $100708.3 | $47970.5 | $87662.01 | $75061.86 |
Interest expense | -$58212.5 | |||
Net income | ||||
Net income | $317250 | $455221.1 | $162486.88 | $108035.97 |
Income (for common shares) | $317250 | $455221.1 | $162486.88 | $108035.97 |
(in millions $) | 31 Mar 2022 | 30 Sep 2021 | 31 Mar 2021 | 30 Sep 2020 |
---|---|---|---|---|
Net income | $236981.1 | $42525.04 | $213434.46 | $68908.5 |
Operating activities | ||||
Depreciation | $142298.5 | -$128851.61 | $255384.71 | $114716.4 |
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | $394261 | -$86274.53 | $472013.93 | $303443 |
Investing activities | ||||
Capital expenditures | -$260738.9 | $245480.79 | -$430005.29 | -$191857.9 |
Investments | ||||
Total cash flows from investing | -$234292.9 | $220417.71 | -$390897.71 | -$179806.9 |
Financing activities | ||||
Dividends paid | -$91378.2 | -$6897.16 | -$30962.94 | -$6097.3 |
Sale and purchase of stock | $79.9 | |||
Net borrowings | -$70616.2 | -$107517.34 | -$3881.16 | -$85625.4 |
Total cash flows from financing | -$182252.6 | -$94960.09 | -$82578.11 | -$107143.7 |
Effect of exchange rate | $745.2 | $1072.06 | -$492.46 | $915.1 |
Change in cash and equivalents | -$21539.3 | $40255.15 | -$1954.35 | $17407.5 |
(in millions $) | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 | 31 Mar 2020 |
---|---|---|---|---|
Net income | $354404.8 | $492940.6 | $213434.46 | $114562.59 |
Operating activities | ||||
Depreciation | $307585.9 | $268831.6 | $255384.71 | $266348.81 |
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | $842113.4 | $780000.4 | $472013.93 | $705929.78 |
Investing activities | ||||
Capital expenditures | -$490039.1 | -$445263.4 | -$430005.29 | -$549849.26 |
Investments | ||||
Total cash flows from investing | -$732090 | -$404772.9 | -$390897.71 | -$534983.14 |
Financing activities | ||||
Dividends paid | -$176089.7 | -$129238.3 | -$30962.94 | -$82972.42 |
Sale and purchase of stock | -$162.01 | |||
Net borrowings | $114857.4 | -$182014.7 | -$3881.16 | -$26267.27 |
Total cash flows from financing | -$129163.5 | -$359790.8 | -$82578.11 | -$167263.64 |
Effect of exchange rate | $1324.8 | -$492.46 | $3392.67 | |
Change in cash and equivalents | -$15039.8 | $16761.5 | -$1954.35 | $7075.67 |
Market cap | N/A |
---|---|
Enterprise value | N/A |
Shares outstanding | N/A |
Revenue | $6.43T |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | $481.61B |
Revenue Q/Q | 1.53% |
Revenue Y/Y | -6.13% |
P/E ratio | N/A |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | N/A |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | N/A |
EPS | N/A |
---|---|
ROA | 7.71% |
ROE | 16.13% |
Debt/Equity | 1.04 |
---|---|
Net debt/EBITDA | N/A |
Current ratio | 1.00 |
Quick ratio | 0.63 |